Close

AMPL Financial Facts

Chemical income: 100.15M
Discontinued operations attributable to Ampal's shareholders: -0.08
See Full Income Statement

Total equity: -236.22M
Held for sale liabilities: 21.58M
See Full Balance Sheet

Ampal-American Israel (AMPL) Earnings

  |   Expand Research on AMPL
Next EPS Date 5/9/24 EPS Growth Rate +100.0%
Average EPS % Beat Rate +33.3% Revenue Growth Rate +8.7%
Average % Move 1-Wk after EPS -8.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/24 Q124 N/A$0.00 N/A N/A$72.28M = N/A N/A
2/20/24 Q423 $0.04$0.03 +$0.01$71.4M$71.51M = Details
11/7/23 Q323 $0.05$0.03 +$0.02$70.6M$70.04M = Details
8/8/23 Q223 $0.02$0.02 $0.00$67.8M$66.9M = Details
9/19/23 Q223 N/A$0.01 N/A N/A$68.85M = N/A N/A
5/9/23 Q123 -$0.04-$0.06 +$0.02$66.5M$65.25M = Details
2/15/23 Q422 -$0.03-$0.04 +$0.01$65.3M$63.55M = Details
11/2/22 Q322 -$0.05-$0.08 +$0.03$45.47M$60.15M = Details